We have written at length about the U.S. Food and Drug Administration’s (FDA’s) actions to promulgate regulations specifying the agency’s authority ...

Highmark Health today announced consolidated financial results for the full-year 2024, reporting $29.4 billion in revenue, $50 million in net income, and $209 million in operating losses. These ...

The beauty and personal care segment is projected to grow from $21 billion this year to $34 billion in the next four years, reports Mint.

In recent years, the in vitro diagnostics (IVD) regulatory landscape in Europe has changed and we are now in the transition from IVD Directive 98/79/EC (IVDD) to In Vitro Medical Devices ...